220 related articles for article (PubMed ID: 12690022)
1. Mortality of hepatitis B surface antigen-positive blood donors in England and Wales.
Crook PD; Jones ME; Hall AJ
Int J Epidemiol; 2003 Feb; 32(1):118-24. PubMed ID: 12690022
[TBL] [Abstract][Full Text] [Related]
2. Mortality of hepatitis B positive blood donors in England and Wales.
Hall AJ; Winter PD; Wright R
Lancet; 1985 Jan; 1(8420):91-3. PubMed ID: 2857035
[TBL] [Abstract][Full Text] [Related]
3. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.
Tanaka H; Tsukuma H; Yamano H; Oshima A; Shibata H
Int J Cancer; 2004 Dec; 112(6):1075-80. PubMed ID: 15386355
[TBL] [Abstract][Full Text] [Related]
4. Cofactors associated with liver disease mortality in an HBsAg-positive Mediterranean cohort: 20 years of follow-up.
Ribes J; Clèries R; Rubió A; Hernández JM; Mazzara R; Madoz P; Casanovas T; Casanova A; Gallen M; Rodríguez C; Moreno V; Bosch FX
Int J Cancer; 2006 Aug; 119(3):687-94. PubMed ID: 16496403
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
Jee SH; Ohrr H; Sull JW; Samet JM
J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
[TBL] [Abstract][Full Text] [Related]
7. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study.
Seo SI; Choi HS; Choi BY; Kim HS; Kim HY; Jang MK
J Med Virol; 2014 Jan; 86(1):124-30. PubMed ID: 24127328
[TBL] [Abstract][Full Text] [Related]
9. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
[TBL] [Abstract][Full Text] [Related]
10. Alcohol-related and hepatocellular cancer deaths by country of birth in England and Wales: analysis of mortality and census data.
Bhala N; Bhopal R; Brock A; Griffiths C; Wild S
J Public Health (Oxf); 2009 Jun; 31(2):250-7. PubMed ID: 19297455
[TBL] [Abstract][Full Text] [Related]
11. Causes of death in people with chronic HBV infection: A population-based cohort study.
Montuclard C; Hamza S; Rollot F; Evrard P; Faivre J; Hillon P; Di Martino V; Minello A
J Hepatol; 2015 Jun; 62(6):1265-71. PubMed ID: 25625233
[TBL] [Abstract][Full Text] [Related]
12. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
15. Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.
Gounder PP; Bulkow LR; Snowball M; Negus S; Spradling PR; Simons BC; McMahon BJ
Aliment Pharmacol Ther; 2016 Jun; 43(11):1197-207. PubMed ID: 27061300
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between serum hepatitis B virus DNA load and hepatocellular carcinoma in Qidong, China: a cohort follow-up study of 14 years].
Sun Y; Chen TY; Lu PX; Wang JB; Wu Y; Zhang QN; Qian GS; Tu H
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(27):1874-7. PubMed ID: 23134955
[TBL] [Abstract][Full Text] [Related]
17. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus.
Simonetti J; Bulkow L; McMahon BJ; Homan C; Snowball M; Negus S; Williams J; Livingston SE
Hepatology; 2010 May; 51(5):1531-7. PubMed ID: 20087968
[TBL] [Abstract][Full Text] [Related]
18. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences.
Evans AA; Chen G; Ross EA; Shen FM; Lin WY; London WT
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):369-76. PubMed ID: 11927497
[TBL] [Abstract][Full Text] [Related]
19. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
20. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
